Results 211 to 220 of about 2,079,858 (263)
Some of the next articles are maybe not open access.

Intravaginal Morphine: An Alternative Route of Administration

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1998
The availability of various dosage forms allows morphine to be administered in a number of ways. However, if the oral and rectal routes are not feasible, the parenteral one may appear to be the only viable option. Morphine was administered by the intravaginal route in a 44‐year‐old woman as an alternative to intravenous patient‐controlled analgesia ...
N J, Ostrop, J, Lamb, G, Reid
openaire   +2 more sources

Buccal versus intravaginal misoprostol administration for cervical ripening

American Journal of Obstetrics and Gynecology, 2002
The purpose of this study was to compare the efficacy of misoprostol that is administered in the buccal pouch with the intravaginal route of administration.One hundred fifty-seven pregnant women with a singleton live gestation, Bishop score of
S J, Carlan   +2 more
openaire   +2 more sources

Induction of labor with intravaginal administration of misoprostol

International Journal of Gynecology & Obstetrics, 1998
AbstractObjective: The purpose of this study was to evaluate the efficacy and safety of intravaginal misoprostol for labor induction. Methods: 110 singleton term pregnancies with or without rupture of membranes were enrolled. Fractionated doses of misoprostol were applied (50–100 μg), every 6 h until a maximum of three doses or beginning of labor ...
R, Rodrigues   +5 more
openaire   +2 more sources

Plasma Progesterone Concentrations After Administration via Intravaginal Rings

Acta Obstetricia et Gynecologica Scandinavica, 1979
Intravaginal rings (IVRs) fabricated from polysiloxane (silastic 382) and containing 708+ or -4.7 mg of progesterone (P) in the polysiloxane core of the ring were tested for efficacy of natural P administration through this route. 8 women volunteered.
T, Bäckström   +2 more
openaire   +2 more sources

Midtrimester pregnancy termination by intravaginal administration of prostaglandin E2

Contraception, 1982
The intravaginal administration of prostaglandin E2 (PGE2) in repeated doses of 20 mg was evaluated for efficacy and safety in 400 midtrimester pregnancy terminations. Patients were assigned to three treatment groups. Group A (232 patients) received PGE2 alone, Group B (106 patients) had prior intracervical laminaria insertion, Group C (62 patients ...
E J, Surrago, J, Robins
openaire   +2 more sources

Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration

Menopause, 2009
Because a previous 1-week study has shown no or minimal changes in the serum levels of dehydroepiandrosterone (DHEA) and its metabolites after up to daily 1.8% (23.4 mg) intravaginal DHEA, the objective of the present study was to investigate the serum steroid levels during a 12-week daily intravaginal administration of 0%, 0.25%, 0.5%, and 1.0% DHEA ...
Fernand, Labrie   +19 more
openaire   +2 more sources

Intravaginal administration of progesterone: enhanced absorption after estrogen treatment

Fertility and Sterility, 1981
A progesterone solution was administered by intravaginal instillation, intramuscular injection, and sublingually to estrogen-deficient women, with or without estradiol (E2) replacement, and serum progesterone (P) concentrations were measured by radioimmunoassay. Intravaginal application to postmenopausal subjects receiving E2 gave the highest values of
B, Villanueva, R F, Casper, S S, Yen
openaire   +2 more sources

Intravaginal administration of isosorbide mononitrate for cervical ripening in prolonged pregnancy: a randomised clinical trial

Journal of Obstetrics and Gynaecology Research, 2019
Prolonged pregnancies are associated with foetal and neonatal complications. This study was performed to evaluate the efficacy of intravaginal isosorbide mononitrate (IMN) for cervical ripening in prolonged pregnancies. 122 pregnant women were recruited.
Masoumeh Mirteimouri   +3 more
semanticscholar   +1 more source

Intravaginal Administration of Conjugated Estrogens in Premenopausal and Postmenopausal Women

International Journal of Gynecology & Obstetrics, 1980
ABSTRACTDaily doses of 0.625 mg of conjugated estrogens were administered intravaginally for 14 days to 12 postmenopausal women (six with highly atrophic and six with slightly atrophic vaginal mucosa), resulting in vaginal mucosae similar to those found in premenopausal women in all 12 subjects.
M, Furuhjelm, E, Karlgren, K, Carlström
openaire   +2 more sources

Intravaginal oestrogen and progestin administration: advantages and disadvantages

Best Practice & Research Clinical Obstetrics & Gynaecology, 2008
The vagina provides a local and a systemic route for delivering hormones for systemic effects and uterine targeting. Due to the 'uterine first-pass effect', hormones concentrate in the uterus and nearby tissues with low systemic exposure. Vaginal oestrogens, progesterone/progestins and danazol are currently used to obtain local (vagina and urethra ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy